| abstract |
The present invention provides a novel steviol glycoside containing xylose. According to the present invention, there is provided a compound represented by formula (1), or a salt or hydrate thereof. (In formula, (i) R<sub>1</sub> represents Xyl(1-2)Glc1- and R<sub>2</sub> represents Glc(1-2)[Glc(1-3)]Glc1-; or (ii) R<sub>1</sub> represents Glc(1-2)[Glc(1-3)]Glc1- and R<sub>2</sub> represents Xyl(1-2)[Glc(1-3)]Glc1-, where Glc represents glucose and Xyl represents xylose.) |